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Ossabaw miniature swine were fed an excess calorie, atherogenic
diet for 6, 9, or 12 months. Increased body weight, hypertension,
and increased plasma cholesterol and triglycerides are described
in Table 1. For more detailed interpretations and conclusions about
the data, see our associated research study, “Biphasic alterations in
coronary smooth muscle Ca2þ regulation during coronary artery
disease progression in metabolic syndrome” McKenney-Drake, et al.
(2016) [1].
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not signiﬁcant.Table
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acquiredPlasma biochemical analysisata format Analyzed
xperimental
factorsMetabolic syndrome was induced by atherogenic diet feeding for 6, 9, and 12
months.xperimental
featuresRepeat cross sectional study of metabolic syndrome induction at different time
points of atherogenic diet feeding.ata source
locationIndianapolis, IN, United States of America.ata accessibility With this articleDValue of the data
 These data could assist researchers in study design for induction of metabolic syndrome.
 Provide previously unreported time-dependent aspects of metabolic syndrome.
 May provide insight toward development of therapies at different time points of metabolic syn-
drome progression.1. Data
Here, we conducted a repeat cross-sectional analysis of metabolic syndrome development in
Ossabaw swine during atherogenic diet feeding for 6, 9, and 12 months, as described in the associated
research study [1]. Ossabaw swine on atherogenic diet had increased body weight, hypertension, and
dyslipidemia, compared to lean controls (Table 1).2. Experimental design, materials and methods
2.1. Animal care
All experimental procedures involving animals were approved by the Institutional Animal Care
and Use Committee at Indiana University School of Medicine with the recommendations outlined by
the National Research Council and the American Veterinary Medical Association Panel on Euthanasia
[2,3]. Six month old Ossabaw miniature swine were fed 1 kg of an excess-calorie atherogenic diet (KT-
324, Purina Test Diet, Richmond, IN; 16% kcal from protein, 41% kcal from complex carbohydrates, 19%
kcal from fructose, and 43% kcal from fat). The feed was supplemented with cholesterol (2.0%),
hydrogenated coconut oil (4.70%), hydrogenated soybean oil (8.40%), cholate (0.70%), and high fruc-
tose corn syrup (5.0%) by weight [4–8] daily for 6 (n¼6), 9 (n¼7), or 12 (n¼9) months. Lean controlOssabaw miniature swine groups.
Lean MetS (6 months) MetS (9 months) MetS (12 months) Signiﬁcance
6275 8972 8777 11672 1249, 64 lean
g/dL) 8476 7572 8277 8172 NS
mmHg) 13177 15079 14374 17077 12, 9, 64 lean
(mmHg) 6372 7775 8574 8975 12, 946, lean
) 5775 383739 546766 247717 9412, 64 lean
2574 3474 98734 4376 9412, 6, lean
M.L. McKenney-Drake et al. / Data in Brief 7 (2016) 1393–1395 1395swine (n¼9) were fed 725 g of a standard diet (5L80, Purina Test Diet, Richmond, IN; 18% kcal from
protein, 71% kcal from complex carbohydrates, and 11% kcal from fat). Swine were housed indivi-
dually with free access to drinking water and on a 12 h light/dark cycle.
2.2. Metabolic phenotyping
Final body weights and blood were obtained at time of sacriﬁce. Plasma was obtained from
heparinized whole blood by centrifugation at 2000 rpm for 20 min. Lipid and glucose biochemistry
was performed by ANTECH Diagnostics (Fishers, IN).
2.3. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 (San Diego, CA). One-way analysis of
variance (ANOVA) with Bonferroni post hoc analysis was performed. Data are represented as
mean7SEM. po0.05 was considered signiﬁcant.Acknowledgements
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